Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.79M Sell
170,000
-220,900
-57% -$12.8M ﹤0.01% 1586
2025
Q4
$29.1M Buy
390,900
+270,000
+223% +$19.4M 0.01% 1041
2025
Q3
$8.84M Sell
120,900
-1,241,300
-91% -$94.5M ﹤0.01% 1758
2025
Q2
$94.2M Buy
1,362,200
+1,336,900
+5,284% +$69.3M 0.02% 491
2025
Q1
$1.14M Sell
25,300
-449,700
-95% -$26.6M ﹤0.01% 3027
2024
Q4
$28.9M Buy
475,000
+50,000
+12% +$2.78M 0.01% 914
2024
Q3
$17.3M Buy
+425,000
New +$14.1M ﹤0.01% 1138
2024
Q2
Sell
-45,000
Closed -$1.68M 4827
2024
Q1
$1.68M Sell
45,000
-696,500
-94% -$27.8M ﹤0.01% 2722
2023
Q4
$36.4M Sell
741,500
-573,500
-44% -$16.6M 0.01% 803
2023
Q3
$28M Buy
+1,315,000
New +$24M 0.02% 665
2023
Q2
Sell
-268,000
Closed -$3.02M 4514
2023
Q1
$3.02M Sell
268,000
-454,900
-63% -$5.73M ﹤0.01% 1895
2022
Q4
$6.99M Buy
+722,900
New +$10.9M ﹤0.01% 1407

Other funds holding AFRM

Barclays's AFRM Position: Q1 2026 in Review

Barclays reduced its Affirm (AFRM) stake by 18% in Q1 2026, selling an estimated $2.78M and leaving 219,459 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Barclays first reported a position in AFRM in Q1 2022 and has held it in 17 quarters since. The position peaked at $33.6M in Q1 2022. 591 funds tracked by Wall St. Rank hold AFRM as of Q1 2026.

  • Barclays held 219,459 shares of Affirm worth $10.1M as of Q1 2026.
  • Barclays sold 48,169 Affirm shares in Q1 2026, an estimated $2.78M.
  • Affirm made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1449 holding.
  • Barclays first reported a position in Affirm in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Affirm position peaked at $33.6M in Q1 2022.
  • 591 funds tracked by Wall St. Rank held Affirm as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.